Journal article · 2026 · Open access
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update
Clinical Pharmacology & Therapeutics, 119(4), 916–927 · Published 31 January 2026 · DOI 10.1002/cpt.70209
In brief
“Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update” is a 2026 journal article by Maud Maillard and 18 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 56 citations as of 17 November 2026, which puts it in the top 1% of works published in 2026 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Clinical Pharmacology & Therapeutics.
- Citations
- 56
- Most cited in
- 2026 (56)
- Field-weighted impact
- 178.58
- References
- 51
- Authors
- 19
Abstract
Thiopurine methyltransferase (TPMT) and Nudix hydrolase 15 (NUDT15) are key enzymes that catabolize thiopurines. Decreased or no-function alleles in TPMT and NUDT15 are associated with reduced or no enzyme activity and predictive of pronounced adverse effects, including severe myelosuppression, that may occur among individuals treated with standard doses of thiopurines. Genetic variants in these genes are present in all world populations; however, their frequency varies by ancestry. In this updated guideline, we provide recommendations for adjusting starting doses of mercaptopurine, thioguanine, and azathioprine based on TPMT and NUDT15 genotypes, including for individuals with variants in both genes (updates on www.clinpgx.org).
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Maillard, M., Schwab, M., Whirl‐Carrillo, M., Moyer, A., Suarez‐Kurtz, G., Pui, C., Stein, C. M., Klein, T. E., Spahn, C., Kwon, S., Hartono, J. L., de Boer, N. K., Ahmad, T., Antillon‐Klussmann, F. G., Caudle, K. E., Kato, M., Yeoh, A. E. J., Schmiegelow, K., & Yang, J. J. (2026). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update. Clinical Pharmacology & Therapeutics, 119(4), 916–927. https://doi.org/10.1002/cpt.70209
MLA 9
Maillard, Maud, et al. “Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update.” Clinical Pharmacology & Therapeutics, vol. 119, no. 4, 2026, pp. 916–927. https://doi.org/10.1002/cpt.70209.
Chicago
Maillard, Maud, Matthias Schwab, Michelle Whirl‐Carrillo, AM Moyer, Guilherme Suarez‐Kurtz, Ching‐Hon Pui, C. Michael Stein, et al. 2026. “Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update.” Clinical Pharmacology & Therapeutics 119 (4): 916–927. https://doi.org/10.1002/cpt.70209.
Harvard
Maillard, M. et al. (2026) ‘Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update’, Clinical Pharmacology & Therapeutics, 119(4), pp. 916–927. doi:10.1002/cpt.70209.
IEEE
M. Maillard et al., “Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update,” Clinical Pharmacology & Therapeutics, vol. 119, no. 4, pp. 916–927, 2026, doi: 10.1002/cpt.70209.
BibTeX
@article{maillard2026clinical,
title = {{Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update}},
author = {Maillard, Maud and Schwab, Matthias and Whirl‐Carrillo, Michelle and Moyer, AM and Suarez‐Kurtz, Guilherme and Pui, Ching‐Hon and Stein, C. Michael and Klein, Teri E. and Spahn, Claire and Kwon, Sooyeon and Hartono, Juanda Leo and de Boer, Nanne K.H. and Ahmad, Tariq and Antillon‐Klussmann, Federico Guillermo and Caudle, Kelly E. and Kato, Motohiro and Yeoh, Allen Eng Juh and Schmiegelow, K. and Yang, Jun J},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2026},
volume = {119},
number = {4},
pages = {916--927},
doi = {10.1002/cpt.70209},
url = {https://doi.org/10.1002/cpt.70209}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- thiopurines
- thiopurine S-methyltransferase
- NUDT15
- TPMT genotype
- dose adjustment
- 6-mercaptopurine
- 6-thioguanine
- azathioprine
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Maillard, M., Schwab, M., Whirl‐Carrillo, M., Moyer, A., Suarez‐Kurtz, G., Pui, C., Stein, C. M., Klein, T. E., Spahn, C., Kwon, S., Hartono, J. L., de Boer, N. K., Ahmad, T., Antillon‐Klussmann, F. G., Caudle, K. E., Kato, M., Yeoh, A. E. J., Schmiegelow, K., & Yang, J. J. (2026). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update. Clinical Pharmacology & Therapeutics, 119(4), 916–927. https://doi.org/10.1002/cpt.70209
How many times has this paper been cited?
56 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.
Who wrote this paper?
Maud Maillard, Matthias Schwab, Michelle Whirl‐Carrillo, AM Moyer, Guilherme Suarez‐Kurtz, Ching‐Hon Pui, C. Michael Stein, Teri E. Klein, Claire Spahn, Sooyeon Kwon, Juanda Leo Hartono, Nanne K.H. de Boer and 7 more.
What is the DOI of this paper?
10.1002/cpt.70209, permanently at https://doi.org/10.1002/cpt.70209. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.